Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case

Marco Esposito, Giulia Maggi, Carmelo Marino, Laura Bottalico, Elisabetta Cagni, Claudia Carbonini, Michelina Casale, Stefania Clemente, Valentina D'Alesio, David Fedele, Francesca Romana Giglioli, Valeria Landoni, Anna Martinotti, Roberta Nigro, Lidia Strigari, Elena Villaggi, Pietro Mancosu

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Purpose: To compare five liver metastasis stereotactic ablative radiotherapy (SABR) plans optimised in fourteen centres with 3D-Conformal-RT, IMRT, VMAT, CyberKnife and Tomotherapy and identify possible dosimetric differences. Methods: Dose prescription was 75 Gy in 3 fractions, normalised at 67%-95% isodose. Results: Excluding few cases, all institutions achieved the planning objectives. Differences up to 40% and 25% in mean dose to liver and PTV were found. No significant correlations between technological factors and DVH for target and OARs were observed; the optimisation strategies selected by the planners played a key role in the planning procedure. Conclusions: The human factor and the constraints imposed to the target volume have a greater dosimetric impact than treatment planning and radiation delivery technology in stereotactic treatment of liver metastases. Significant differences found both in terms of dosimetric target coverage and OAR sparing should be taken into consideration before starting a multi-institutional SARB clinical trial.

Original languageEnglish
Pages (from-to)277-83
Number of pages6
JournalPhysica Medica
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

liver
planning
radiation therapy
Radiotherapy
metastasis
Liver
Neoplasm Metastasis
dosage
Prescriptions
delivery
Therapeutics
Clinical Trials
Radiation
Technology
optimization
radiation

Keywords

  • Dosimetry
  • Liver
  • Multicentric clinical trial
  • Stereotactic ablative radiotherapy (SABR)
  • Stereotactic body radiation therapy (SBRT)

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Cite this

Multicentre treatment planning inter-comparison in a national context : The liver stereotactic ablative radiotherapy case. / Esposito, Marco; Maggi, Giulia; Marino, Carmelo; Bottalico, Laura; Cagni, Elisabetta; Carbonini, Claudia; Casale, Michelina; Clemente, Stefania; D'Alesio, Valentina; Fedele, David; Giglioli, Francesca Romana; Landoni, Valeria; Martinotti, Anna; Nigro, Roberta; Strigari, Lidia; Villaggi, Elena; Mancosu, Pietro.

In: Physica Medica, 01.01.2016, p. 277-83.

Research output: Contribution to journalArticle

Esposito, M, Maggi, G, Marino, C, Bottalico, L, Cagni, E, Carbonini, C, Casale, M, Clemente, S, D'Alesio, V, Fedele, D, Giglioli, FR, Landoni, V, Martinotti, A, Nigro, R, Strigari, L, Villaggi, E & Mancosu, P 2016, 'Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case', Physica Medica, pp. 277-83. https://doi.org/10.1016/j.ejmp.2015.09.009
Esposito, Marco ; Maggi, Giulia ; Marino, Carmelo ; Bottalico, Laura ; Cagni, Elisabetta ; Carbonini, Claudia ; Casale, Michelina ; Clemente, Stefania ; D'Alesio, Valentina ; Fedele, David ; Giglioli, Francesca Romana ; Landoni, Valeria ; Martinotti, Anna ; Nigro, Roberta ; Strigari, Lidia ; Villaggi, Elena ; Mancosu, Pietro. / Multicentre treatment planning inter-comparison in a national context : The liver stereotactic ablative radiotherapy case. In: Physica Medica. 2016 ; pp. 277-83.
@article{1c3180c3fbc24295a9888b331f37af89,
title = "Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case",
abstract = "Purpose: To compare five liver metastasis stereotactic ablative radiotherapy (SABR) plans optimised in fourteen centres with 3D-Conformal-RT, IMRT, VMAT, CyberKnife and Tomotherapy and identify possible dosimetric differences. Methods: Dose prescription was 75 Gy in 3 fractions, normalised at 67{\%}-95{\%} isodose. Results: Excluding few cases, all institutions achieved the planning objectives. Differences up to 40{\%} and 25{\%} in mean dose to liver and PTV were found. No significant correlations between technological factors and DVH for target and OARs were observed; the optimisation strategies selected by the planners played a key role in the planning procedure. Conclusions: The human factor and the constraints imposed to the target volume have a greater dosimetric impact than treatment planning and radiation delivery technology in stereotactic treatment of liver metastases. Significant differences found both in terms of dosimetric target coverage and OAR sparing should be taken into consideration before starting a multi-institutional SARB clinical trial.",
keywords = "Dosimetry, Liver, Multicentric clinical trial, Stereotactic ablative radiotherapy (SABR), Stereotactic body radiation therapy (SBRT)",
author = "Marco Esposito and Giulia Maggi and Carmelo Marino and Laura Bottalico and Elisabetta Cagni and Claudia Carbonini and Michelina Casale and Stefania Clemente and Valentina D'Alesio and David Fedele and Giglioli, {Francesca Romana} and Valeria Landoni and Anna Martinotti and Roberta Nigro and Lidia Strigari and Elena Villaggi and Pietro Mancosu",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.ejmp.2015.09.009",
language = "English",
pages = "277--83",
journal = "Physica Medica",
issn = "1120-1797",
publisher = "Associazione Italiana di Fisica Medica",

}

TY - JOUR

T1 - Multicentre treatment planning inter-comparison in a national context

T2 - The liver stereotactic ablative radiotherapy case

AU - Esposito, Marco

AU - Maggi, Giulia

AU - Marino, Carmelo

AU - Bottalico, Laura

AU - Cagni, Elisabetta

AU - Carbonini, Claudia

AU - Casale, Michelina

AU - Clemente, Stefania

AU - D'Alesio, Valentina

AU - Fedele, David

AU - Giglioli, Francesca Romana

AU - Landoni, Valeria

AU - Martinotti, Anna

AU - Nigro, Roberta

AU - Strigari, Lidia

AU - Villaggi, Elena

AU - Mancosu, Pietro

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose: To compare five liver metastasis stereotactic ablative radiotherapy (SABR) plans optimised in fourteen centres with 3D-Conformal-RT, IMRT, VMAT, CyberKnife and Tomotherapy and identify possible dosimetric differences. Methods: Dose prescription was 75 Gy in 3 fractions, normalised at 67%-95% isodose. Results: Excluding few cases, all institutions achieved the planning objectives. Differences up to 40% and 25% in mean dose to liver and PTV were found. No significant correlations between technological factors and DVH for target and OARs were observed; the optimisation strategies selected by the planners played a key role in the planning procedure. Conclusions: The human factor and the constraints imposed to the target volume have a greater dosimetric impact than treatment planning and radiation delivery technology in stereotactic treatment of liver metastases. Significant differences found both in terms of dosimetric target coverage and OAR sparing should be taken into consideration before starting a multi-institutional SARB clinical trial.

AB - Purpose: To compare five liver metastasis stereotactic ablative radiotherapy (SABR) plans optimised in fourteen centres with 3D-Conformal-RT, IMRT, VMAT, CyberKnife and Tomotherapy and identify possible dosimetric differences. Methods: Dose prescription was 75 Gy in 3 fractions, normalised at 67%-95% isodose. Results: Excluding few cases, all institutions achieved the planning objectives. Differences up to 40% and 25% in mean dose to liver and PTV were found. No significant correlations between technological factors and DVH for target and OARs were observed; the optimisation strategies selected by the planners played a key role in the planning procedure. Conclusions: The human factor and the constraints imposed to the target volume have a greater dosimetric impact than treatment planning and radiation delivery technology in stereotactic treatment of liver metastases. Significant differences found both in terms of dosimetric target coverage and OAR sparing should be taken into consideration before starting a multi-institutional SARB clinical trial.

KW - Dosimetry

KW - Liver

KW - Multicentric clinical trial

KW - Stereotactic ablative radiotherapy (SABR)

KW - Stereotactic body radiation therapy (SBRT)

UR - http://www.scopus.com/inward/record.url?scp=84951189864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951189864&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2015.09.009

DO - 10.1016/j.ejmp.2015.09.009

M3 - Article

AN - SCOPUS:84951189864

SP - 277

EP - 283

JO - Physica Medica

JF - Physica Medica

SN - 1120-1797

ER -